Turmeric Acquisition Corp. (NASDAQ:TMPM) announced this morning that it has opted to liquidate its trust, dispersing approximately $10.05 per share to holders.
The SPAC’s shares will cease trading as of the open on October 20. Turmeric will hold on to up to $100,000 of accrued interest to pay for dissolution expenses.
Turmeric originally raised $97.8 million in its October 2020 IPO and endeavored to combine with an “off-the-radar” life sciences company with promising drug candidates for oncology or rare diseases. This has been a particularly tricky field for SPACs seeking to achieve near-term returns in recent years.
Of the 33 drug discovery or development biotech companies that have completed SPAC transactions dating back to May 2019, only one closed Friday above $10 – Immatics Biotechnologies (NASDAQ:IMTX). It completed its combination with ARYA Sciences I in June 2020.
Turmeric becomes the 35th SPAC to announce its intention to liquidate in 2022, 28 of which have already completed their liquidations.
Cayson Acquisition Corp. (NASDAQ:CAPN) has entered into a definitive agreement to combine with boutique investment firm Mango Financial for $300 million in equity consideration. Hong Kong-based Mango provides a range of M&A and equity capital markets advisory services to clients considering listings in China and the US. The combined company is expected to trade on...
Trailblazer (NASDAQ:BLZRU) has filed for a $200 million SPAC to bring a first-time team to market with serial sponsor terms. The new SPAC is offering investors a 1/3 warrant in each unit and it is the first SPAC filed so far this month with 24 months on its initial transaction clock. All other July SPACs...
This week, we speak with Kyivstar CEO Oleksandr Komarov about the company’s $2.2 billion dollar combination with Cohen Circle Acquisition Corp. I (NASDAQ:CCIR). Few companies have been had to forge themselves in the flames recently quite like Ukraine’s leading telecom and digital services provider Kyivstar. Now, Kyivstar is not only telling that story but pitching it to...
At the SPAC of Dawn The market still has one full trading session before it adds Tuesday’s Core CPI reading and a variety of Fed comments to messaging it is already ingesting on US President Donald Trump’s ever-shifting tariff policy. SPACs are meanwhile continuing on with business as usual, with Cayson (NASDAQ:CAPN) announcing the third...
Terms Tracker for the Week Ending July 11, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. One more IPO priced this week bringing July’s total to 8. However, there are still three more weeks left in the month so that number...